Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

We recently compiled a list of the 10 High-Flying Stocks to Buy Now. In this article, we are going to take a look at where ...

Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...

Shares of Novavax Inc. NVAX slid 4.34% to $13.02 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.18% to 17,923.90 ...

Novavax (NVAX) shares climbed 15% Wednesday after Jefferies released a bullish note on the company’s prospects after meeting ...

Novavax (NVAX) stock fell after a clarification on an analyst report led to a sharp rally in the company stock in the ...

The mRNA-based supplier of vaccines profited from Covid-19 vaccine sales. As the years passed, Covid evolved. The weaker ...

On Thursday, Novavax Inc (NVAX) stock saw a decline, ending the day at $14.42 which represents a decrease of $-0.26 or -1.77% from the prior close of $14.68. The stock opened at $14.07 and touched a ...

In a report released today, Roger Song from Jefferies maintained a Buy rating on Novavax (NVAX – Research Report), with a price target of ...

Novavax (NVAX) shares soared 19.2% in the last trading session to close at $14.68. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares ...

Novavax (NVAX) closed at $14.42 in the latest trading session, marking a -1.77% move from the prior day. This change lagged the S&P 500's daily loss of 0.17%. Elsewhere, the Dow saw a downswing of ...